SlideShare a Scribd company logo
ASCOT-CRP (Anglo-Scandinavian Cardiac
Outcomes Trial—C-Reactive Protein)
ASCOT-CRP (Anglo-Scandinavian Cardiac
Outcomes Trial—C-Reactive Protein)
PS Sever (Imperial College, London, UK)
American Heart Association 2010 Scientific Sessions



• A post hoc analysis of the trial's lipid-lowering arm designed to evaluate the
  importance of high-sensitivity C-reactive protein (hs-CRP) in measuring CV risk
• Included 485 patients:
    Who reached the composite end point (CV death, nonfatal MI, coronary
    revascularization, or fatal/nonfatal stroke)
    Were age- and sex-matched to 1367 patients in the control group who hadn't
    suffered one of those events
    Were followed for 5.5 years
ASCOT-CRP: Results

Measuring hs-CRP had little to no utility in refining CV risk assessment beyond
classic risk factors
• Baseline levels of hs-CRP and LDL-C were significantly correlated with each other
  (p<0.0001) and both were predictive of the composite CV end point:
    OR 1.31 (95% CI 1.10–1.56; p=0.002) for LDL-C
    OR 1.19 (95% CI 1.05–1.34; p=0.006) for every one–standard-deviation increase
    in hs-CRP
• Lower on-treatment LDL-C but not hs-CRP was associated with a highly significant
  reduction in CV events over six months:
    LDL-C <2.1 mmol/L (median) vs LDL-C ≥ 2.1 mmol/L predicted a reduction in the
    composite end point (adjusted OR=0.41, 95% CI 0.22–0.75; p=0.004)
    hs-CRP <1.83 mg/L (median) vs hs-CRP ≥ 1.83 mg/L showed no such predictive
    effect (adjusted OR=0.86, 95% CI 0.49–1.51; p=0.60)
ASCOT-CRP: Commentary*

"It is clear that achievement of low LDL-cholesterol levels confers great benefit, and
there's no added benefit by achieving a lower CRP level."
                                                                    - Dr Peter S Sever


"I'm not as convinced as Dr Sever that this damages the CRP hypothesis."

                                                                                      - Dr Roger Blumenthal


"It's a post hoc analysis of a previously published trial and we must take it with a
grain of salt. It was a particularly high-risk primary-prevention cohort, and it's fair to
say there were a relatively small number of events."
                                                                - Dr Donald Lloyd Jones


*All comments from ASCOT analysis fuels debate over JUPITER-based CRP indication for statins
 (http://www.theheart.org/article/1153661.do)
Become a member of http://www.theheart.org
    Become a fan on Facebook: http://www.facebook.com/theheartorg
          Follow us on Twitter: http://www.twitter.com/theheartorg

theheart.org is the leading online source of independent cardiology news.
We are the top provider of news and opinions for over 100 000 physicians.

More Related Content

Viewers also liked

Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
IPMS- KMU KPK PAKISTAN
 
Complications of DM
Complications of DMComplications of DM
Complications of DM
snich
 
Diabetic retinopathy (opthalmology)
Diabetic retinopathy (opthalmology)Diabetic retinopathy (opthalmology)
Diabetic retinopathy (opthalmology)
Ma Wady
 
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITINInterpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
Jyothi Reshma S
 
Diabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathyDiabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathy
raj kumar
 
CRP and inflammatory response (1)
CRP and inflammatory response (1)CRP and inflammatory response (1)
CRP and inflammatory response (1)
Montse Juvany
 
Diabetic Nephropathy
Diabetic NephropathyDiabetic Nephropathy
Diabetic Nephropathy
Upendra Reddy
 
Diabetic p. neuropathy
Diabetic p. neuropathyDiabetic p. neuropathy
Diabetic p. neuropathy
Mohammad Othman Daoud
 
Chronic complication of diabetes melitus
Chronic complication of diabetes melitusChronic complication of diabetes melitus
Chronic complication of diabetes melitus
Nur Idris
 
Lecture 3: Diabetic Retinopathy
Lecture 3: Diabetic RetinopathyLecture 3: Diabetic Retinopathy
Lecture 3: Diabetic Retinopathy
Munish Sharma MD OD
 
CRP and inflammatory response (2)
CRP and inflammatory response (2)CRP and inflammatory response (2)
CRP and inflammatory response (2)
Montse Juvany
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
OPTOM FASLU MUHAMMED
 
Lecture 1: Hematology introducion For TID and HIV Medicine MSc students
Lecture 1: Hematology introducion For TID and HIV Medicine MSc studentsLecture 1: Hematology introducion For TID and HIV Medicine MSc students
Lecture 1: Hematology introducion For TID and HIV Medicine MSc students
Mulugeta Gobezie
 
Soffacation (suicidal)
Soffacation (suicidal)Soffacation (suicidal)
Soffacation (suicidal)
Ma Wady
 
CRP Presentation
CRP PresentationCRP Presentation
CRP Presentation
kashif81
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
Ankur Varshney
 
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
Shahid Nawaz
 
Diabetic Retinopathy
Diabetic RetinopathyDiabetic Retinopathy
Diabetic Retinopathy
Devin Prabhakar
 
Automation in hematology part 1
Automation in hematology part 1Automation in hematology part 1
Automation in hematology part 1
Dr. Varughese George
 

Viewers also liked (19)

Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
 
Complications of DM
Complications of DMComplications of DM
Complications of DM
 
Diabetic retinopathy (opthalmology)
Diabetic retinopathy (opthalmology)Diabetic retinopathy (opthalmology)
Diabetic retinopathy (opthalmology)
 
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITINInterpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
 
Diabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathyDiabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathy
 
CRP and inflammatory response (1)
CRP and inflammatory response (1)CRP and inflammatory response (1)
CRP and inflammatory response (1)
 
Diabetic Nephropathy
Diabetic NephropathyDiabetic Nephropathy
Diabetic Nephropathy
 
Diabetic p. neuropathy
Diabetic p. neuropathyDiabetic p. neuropathy
Diabetic p. neuropathy
 
Chronic complication of diabetes melitus
Chronic complication of diabetes melitusChronic complication of diabetes melitus
Chronic complication of diabetes melitus
 
Lecture 3: Diabetic Retinopathy
Lecture 3: Diabetic RetinopathyLecture 3: Diabetic Retinopathy
Lecture 3: Diabetic Retinopathy
 
CRP and inflammatory response (2)
CRP and inflammatory response (2)CRP and inflammatory response (2)
CRP and inflammatory response (2)
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Lecture 1: Hematology introducion For TID and HIV Medicine MSc students
Lecture 1: Hematology introducion For TID and HIV Medicine MSc studentsLecture 1: Hematology introducion For TID and HIV Medicine MSc students
Lecture 1: Hematology introducion For TID and HIV Medicine MSc students
 
Soffacation (suicidal)
Soffacation (suicidal)Soffacation (suicidal)
Soffacation (suicidal)
 
CRP Presentation
CRP PresentationCRP Presentation
CRP Presentation
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
 
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
 
Diabetic Retinopathy
Diabetic RetinopathyDiabetic Retinopathy
Diabetic Retinopathy
 
Automation in hematology part 1
Automation in hematology part 1Automation in hematology part 1
Automation in hematology part 1
 

More from theheart.org

TCT 2012 research highlights: A slideshow presentation
TCT 2012 research highlights: A slideshow presentationTCT 2012 research highlights: A slideshow presentation
TCT 2012 research highlights: A slideshow presentation
theheart.org
 
ESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentationESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentation
theheart.org
 
AHA 2012 Research Highlights
AHA 2012 Research HighlightsAHA 2012 Research Highlights
AHA 2012 Research Highlights
theheart.org
 
AHA 2010 research highlights: A slideshow presentation
AHA 2010 research highlights: A slideshow presentation AHA 2010 research highlights: A slideshow presentation
AHA 2010 research highlights: A slideshow presentation
theheart.org
 
TCT 2010 research highlights: A slideshow presentation
TCT 2010 research highlights: A slideshow presentation TCT 2010 research highlights: A slideshow presentation
TCT 2010 research highlights: A slideshow presentation
theheart.org
 
ESC 2010 Research Highlights : A slideshow presentation
ESC 2010 Research Highlights : A slideshow presentationESC 2010 Research Highlights : A slideshow presentation
ESC 2010 Research Highlights : A slideshow presentation
theheart.org
 
CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results
theheart.org
 
ONTARGET trial - Summary & Results with Ramipril Global Endpoint
ONTARGET trial - Summary & Results with Ramipril Global EndpointONTARGET trial - Summary & Results with Ramipril Global Endpoint
ONTARGET trial - Summary & Results with Ramipril Global Endpoint
theheart.org
 
OASIS-6 trial - Summary & Results at ACC
OASIS-6 trial - Summary & Results at ACCOASIS-6 trial - Summary & Results at ACC
OASIS-6 trial - Summary & Results at ACC
theheart.org
 
IDEAL trial - Summary & Results
IDEAL trial - Summary & ResultsIDEAL trial - Summary & Results
IDEAL trial - Summary & Results
theheart.org
 
PURE trial - Summary & Results
PURE trial - Summary & ResultsPURE trial - Summary & Results
PURE trial - Summary & Results
theheart.org
 
ACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & ResultsACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & Results
theheart.org
 
RIVAL trial - Summary & Results
RIVAL trial - Summary & ResultsRIVAL trial - Summary & Results
RIVAL trial - Summary & Results
theheart.org
 
ACT trial - Summary & Results
ACT trial - Summary & ResultsACT trial - Summary & Results
ACT trial - Summary & Results
theheart.org
 
P-OM3 trial - Summary & Results
P-OM3 trial - Summary & ResultsP-OM3 trial - Summary & Results
P-OM3 trial - Summary & Results
theheart.org
 
TRITON-TIMI 38 trial - Summary & Results
TRITON-TIMI 38 trial - Summary & ResultsTRITON-TIMI 38 trial - Summary & Results
TRITON-TIMI 38 trial - Summary & Results
theheart.org
 
SHIFT trial - Summary & Results
SHIFT trial - Summary & ResultsSHIFT trial - Summary & Results
SHIFT trial - Summary & Results
theheart.org
 
PROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & ResultsPROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & Results
theheart.org
 
PRELUDE trial - Summary & Results
PRELUDE trial - Summary & ResultsPRELUDE trial - Summary & Results
PRELUDE trial - Summary & Results
theheart.org
 
ALTITUDE trial - Summary & Results
ALTITUDE trial - Summary & ResultsALTITUDE trial - Summary & Results
ALTITUDE trial - Summary & Results
theheart.org
 

More from theheart.org (20)

TCT 2012 research highlights: A slideshow presentation
TCT 2012 research highlights: A slideshow presentationTCT 2012 research highlights: A slideshow presentation
TCT 2012 research highlights: A slideshow presentation
 
ESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentationESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentation
 
AHA 2012 Research Highlights
AHA 2012 Research HighlightsAHA 2012 Research Highlights
AHA 2012 Research Highlights
 
AHA 2010 research highlights: A slideshow presentation
AHA 2010 research highlights: A slideshow presentation AHA 2010 research highlights: A slideshow presentation
AHA 2010 research highlights: A slideshow presentation
 
TCT 2010 research highlights: A slideshow presentation
TCT 2010 research highlights: A slideshow presentation TCT 2010 research highlights: A slideshow presentation
TCT 2010 research highlights: A slideshow presentation
 
ESC 2010 Research Highlights : A slideshow presentation
ESC 2010 Research Highlights : A slideshow presentationESC 2010 Research Highlights : A slideshow presentation
ESC 2010 Research Highlights : A slideshow presentation
 
CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results
 
ONTARGET trial - Summary & Results with Ramipril Global Endpoint
ONTARGET trial - Summary & Results with Ramipril Global EndpointONTARGET trial - Summary & Results with Ramipril Global Endpoint
ONTARGET trial - Summary & Results with Ramipril Global Endpoint
 
OASIS-6 trial - Summary & Results at ACC
OASIS-6 trial - Summary & Results at ACCOASIS-6 trial - Summary & Results at ACC
OASIS-6 trial - Summary & Results at ACC
 
IDEAL trial - Summary & Results
IDEAL trial - Summary & ResultsIDEAL trial - Summary & Results
IDEAL trial - Summary & Results
 
PURE trial - Summary & Results
PURE trial - Summary & ResultsPURE trial - Summary & Results
PURE trial - Summary & Results
 
ACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & ResultsACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & Results
 
RIVAL trial - Summary & Results
RIVAL trial - Summary & ResultsRIVAL trial - Summary & Results
RIVAL trial - Summary & Results
 
ACT trial - Summary & Results
ACT trial - Summary & ResultsACT trial - Summary & Results
ACT trial - Summary & Results
 
P-OM3 trial - Summary & Results
P-OM3 trial - Summary & ResultsP-OM3 trial - Summary & Results
P-OM3 trial - Summary & Results
 
TRITON-TIMI 38 trial - Summary & Results
TRITON-TIMI 38 trial - Summary & ResultsTRITON-TIMI 38 trial - Summary & Results
TRITON-TIMI 38 trial - Summary & Results
 
SHIFT trial - Summary & Results
SHIFT trial - Summary & ResultsSHIFT trial - Summary & Results
SHIFT trial - Summary & Results
 
PROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & ResultsPROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & Results
 
PRELUDE trial - Summary & Results
PRELUDE trial - Summary & ResultsPRELUDE trial - Summary & Results
PRELUDE trial - Summary & Results
 
ALTITUDE trial - Summary & Results
ALTITUDE trial - Summary & ResultsALTITUDE trial - Summary & Results
ALTITUDE trial - Summary & Results
 

Recently uploaded

STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
shruti jagirdar
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
Gokuldas Hospital
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
MwambaChikonde1
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Planet Ayurveda
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
Jyoti Bhaghasra
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
MuskanShingari
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Mobile Problem
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
NarminHamaaminHussen
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOWPune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Get New Sim
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 

Recently uploaded (20)

STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOWPune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 

ASCOT-CRP trial - Summary & Results

  • 2. ASCOT-CRP (Anglo-Scandinavian Cardiac Outcomes Trial—C-Reactive Protein) PS Sever (Imperial College, London, UK) American Heart Association 2010 Scientific Sessions • A post hoc analysis of the trial's lipid-lowering arm designed to evaluate the importance of high-sensitivity C-reactive protein (hs-CRP) in measuring CV risk • Included 485 patients: Who reached the composite end point (CV death, nonfatal MI, coronary revascularization, or fatal/nonfatal stroke) Were age- and sex-matched to 1367 patients in the control group who hadn't suffered one of those events Were followed for 5.5 years
  • 3. ASCOT-CRP: Results Measuring hs-CRP had little to no utility in refining CV risk assessment beyond classic risk factors • Baseline levels of hs-CRP and LDL-C were significantly correlated with each other (p<0.0001) and both were predictive of the composite CV end point: OR 1.31 (95% CI 1.10–1.56; p=0.002) for LDL-C OR 1.19 (95% CI 1.05–1.34; p=0.006) for every one–standard-deviation increase in hs-CRP • Lower on-treatment LDL-C but not hs-CRP was associated with a highly significant reduction in CV events over six months: LDL-C <2.1 mmol/L (median) vs LDL-C ≥ 2.1 mmol/L predicted a reduction in the composite end point (adjusted OR=0.41, 95% CI 0.22–0.75; p=0.004) hs-CRP <1.83 mg/L (median) vs hs-CRP ≥ 1.83 mg/L showed no such predictive effect (adjusted OR=0.86, 95% CI 0.49–1.51; p=0.60)
  • 4. ASCOT-CRP: Commentary* "It is clear that achievement of low LDL-cholesterol levels confers great benefit, and there's no added benefit by achieving a lower CRP level." - Dr Peter S Sever "I'm not as convinced as Dr Sever that this damages the CRP hypothesis." - Dr Roger Blumenthal "It's a post hoc analysis of a previously published trial and we must take it with a grain of salt. It was a particularly high-risk primary-prevention cohort, and it's fair to say there were a relatively small number of events." - Dr Donald Lloyd Jones *All comments from ASCOT analysis fuels debate over JUPITER-based CRP indication for statins (http://www.theheart.org/article/1153661.do)
  • 5. Become a member of http://www.theheart.org Become a fan on Facebook: http://www.facebook.com/theheartorg Follow us on Twitter: http://www.twitter.com/theheartorg theheart.org is the leading online source of independent cardiology news. We are the top provider of news and opinions for over 100 000 physicians.